Nivolumab-Induced de novo Discoid Lupus Erythematosus
An increasing number of checkpoint inhibitor-induced subacute cutaneous lupus erythematosus events have been reported. We present the first case of nivolumab-induced discoid lupus erythematosus in a patient with hepatocellular carcinoma. The patient presents with violaceous hypopigmented plaques on...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-04-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/523800 |